| Family Health Care & Minor Emergency Clinic Inc | |
|
11109 Surrey Hills Blvd Yukon OK 73099-8155 | |
| (405) 373-2400 | |
| (405) 373-4400 |
| Full Name | Family Health Care & Minor Emergency Clinic Inc |
|---|---|
| Speciality | Clinic/Center |
| Location | 11109 Surrey Hills Blvd, Yukon, Oklahoma |
| Authorized Official Name and Position | Antonia Pratt-reid (CEO) |
| Authorized Official Contact | 4053732400 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Family Health Care & Minor Emergency Clinic Inc Po Box 660 Piedmont OK 73078-0660 Ph: (405) 373-2400 | Family Health Care & Minor Emergency Clinic Inc 11109 Surrey Hills Blvd Yukon OK 73099-8155 Ph: (405) 373-2400 |
| NPI Number | 1548355134 |
|---|---|
| Provider Enumeration Date | 10/03/2006 |
| Last Update Date | 02/18/2016 |
| Medicare PECOS PAC ID | 8729075650 |
|---|---|
| Medicare Enrollment ID | O20040430000458 |
News Archive
University of Utah researchers have received $1.4 million to further develop an implantable neural interface that will allow an amputee to move an advanced prosthetic hand with just his or her thoughts. The neural interface will also convey feelings of touch and movement.
Findings published in the BMJ suggest that malaria is being significantly misdiagnosed in Afghanistan, with many patients with fever alone being given antimalarial drugs and antibiotics despite having negative laboratory results for the disease.
A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the drug hydroxychloroquine can benefit people infected with COVID-19, as well as whether taking the drug preventatively may help people avoid infection altogether.
Sheba Medical Center at Tel HaShomer and Immunicom, Inc. are initiating a ground-breaking clinical trial to evaluate the clinical effectiveness of the Immunicom LW-02 plasma filtration device as a monotherapy and in combination with an anti-PD-1 immune checkpoint inhibitor.
Prescription Solutions, a leading pharmacy benefits management (PBM) organization and a UnitedHealth Group (NYSE:UNH) company, today announced that it received the highest rankings for customer service and cost competitiveness factors among mail order pharmacies in the J.D. Power and Associates 2009 National Pharmacy StudySM.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548355134 | NPI | - | NPPES |
| 200010210B | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | (* (Not Available)) | Primary |
| Provider Name | Brett A Germany |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1295796225 PECOS PAC ID: 2668400839 Enrollment ID: I20050728001238 |
News Archive
University of Utah researchers have received $1.4 million to further develop an implantable neural interface that will allow an amputee to move an advanced prosthetic hand with just his or her thoughts. The neural interface will also convey feelings of touch and movement.
Findings published in the BMJ suggest that malaria is being significantly misdiagnosed in Afghanistan, with many patients with fever alone being given antimalarial drugs and antibiotics despite having negative laboratory results for the disease.
A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the drug hydroxychloroquine can benefit people infected with COVID-19, as well as whether taking the drug preventatively may help people avoid infection altogether.
Sheba Medical Center at Tel HaShomer and Immunicom, Inc. are initiating a ground-breaking clinical trial to evaluate the clinical effectiveness of the Immunicom LW-02 plasma filtration device as a monotherapy and in combination with an anti-PD-1 immune checkpoint inhibitor.
Prescription Solutions, a leading pharmacy benefits management (PBM) organization and a UnitedHealth Group (NYSE:UNH) company, today announced that it received the highest rankings for customer service and cost competitiveness factors among mail order pharmacies in the J.D. Power and Associates 2009 National Pharmacy StudySM.
› Verified 3 days ago
| Provider Name | Antonia M Pratt-reid |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1477595635 PECOS PAC ID: 9335136266 Enrollment ID: I20060707000138 |
News Archive
University of Utah researchers have received $1.4 million to further develop an implantable neural interface that will allow an amputee to move an advanced prosthetic hand with just his or her thoughts. The neural interface will also convey feelings of touch and movement.
Findings published in the BMJ suggest that malaria is being significantly misdiagnosed in Afghanistan, with many patients with fever alone being given antimalarial drugs and antibiotics despite having negative laboratory results for the disease.
A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the drug hydroxychloroquine can benefit people infected with COVID-19, as well as whether taking the drug preventatively may help people avoid infection altogether.
Sheba Medical Center at Tel HaShomer and Immunicom, Inc. are initiating a ground-breaking clinical trial to evaluate the clinical effectiveness of the Immunicom LW-02 plasma filtration device as a monotherapy and in combination with an anti-PD-1 immune checkpoint inhibitor.
Prescription Solutions, a leading pharmacy benefits management (PBM) organization and a UnitedHealth Group (NYSE:UNH) company, today announced that it received the highest rankings for customer service and cost competitiveness factors among mail order pharmacies in the J.D. Power and Associates 2009 National Pharmacy StudySM.
› Verified 3 days ago
| Provider Name | Cene L Livingston |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1225070485 PECOS PAC ID: 1658377502 Enrollment ID: I20061017000065 |
News Archive
University of Utah researchers have received $1.4 million to further develop an implantable neural interface that will allow an amputee to move an advanced prosthetic hand with just his or her thoughts. The neural interface will also convey feelings of touch and movement.
Findings published in the BMJ suggest that malaria is being significantly misdiagnosed in Afghanistan, with many patients with fever alone being given antimalarial drugs and antibiotics despite having negative laboratory results for the disease.
A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the drug hydroxychloroquine can benefit people infected with COVID-19, as well as whether taking the drug preventatively may help people avoid infection altogether.
Sheba Medical Center at Tel HaShomer and Immunicom, Inc. are initiating a ground-breaking clinical trial to evaluate the clinical effectiveness of the Immunicom LW-02 plasma filtration device as a monotherapy and in combination with an anti-PD-1 immune checkpoint inhibitor.
Prescription Solutions, a leading pharmacy benefits management (PBM) organization and a UnitedHealth Group (NYSE:UNH) company, today announced that it received the highest rankings for customer service and cost competitiveness factors among mail order pharmacies in the J.D. Power and Associates 2009 National Pharmacy StudySM.
› Verified 3 days ago
| Provider Name | Michelle L Johnston |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1316122039 PECOS PAC ID: 4880744549 Enrollment ID: I20090618000346 |
News Archive
University of Utah researchers have received $1.4 million to further develop an implantable neural interface that will allow an amputee to move an advanced prosthetic hand with just his or her thoughts. The neural interface will also convey feelings of touch and movement.
Findings published in the BMJ suggest that malaria is being significantly misdiagnosed in Afghanistan, with many patients with fever alone being given antimalarial drugs and antibiotics despite having negative laboratory results for the disease.
A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the drug hydroxychloroquine can benefit people infected with COVID-19, as well as whether taking the drug preventatively may help people avoid infection altogether.
Sheba Medical Center at Tel HaShomer and Immunicom, Inc. are initiating a ground-breaking clinical trial to evaluate the clinical effectiveness of the Immunicom LW-02 plasma filtration device as a monotherapy and in combination with an anti-PD-1 immune checkpoint inhibitor.
Prescription Solutions, a leading pharmacy benefits management (PBM) organization and a UnitedHealth Group (NYSE:UNH) company, today announced that it received the highest rankings for customer service and cost competitiveness factors among mail order pharmacies in the J.D. Power and Associates 2009 National Pharmacy StudySM.
› Verified 3 days ago
| Provider Name | David Holland |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1912109885 PECOS PAC ID: 6305010547 Enrollment ID: I20111128000137 |
News Archive
University of Utah researchers have received $1.4 million to further develop an implantable neural interface that will allow an amputee to move an advanced prosthetic hand with just his or her thoughts. The neural interface will also convey feelings of touch and movement.
Findings published in the BMJ suggest that malaria is being significantly misdiagnosed in Afghanistan, with many patients with fever alone being given antimalarial drugs and antibiotics despite having negative laboratory results for the disease.
A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the drug hydroxychloroquine can benefit people infected with COVID-19, as well as whether taking the drug preventatively may help people avoid infection altogether.
Sheba Medical Center at Tel HaShomer and Immunicom, Inc. are initiating a ground-breaking clinical trial to evaluate the clinical effectiveness of the Immunicom LW-02 plasma filtration device as a monotherapy and in combination with an anti-PD-1 immune checkpoint inhibitor.
Prescription Solutions, a leading pharmacy benefits management (PBM) organization and a UnitedHealth Group (NYSE:UNH) company, today announced that it received the highest rankings for customer service and cost competitiveness factors among mail order pharmacies in the J.D. Power and Associates 2009 National Pharmacy StudySM.
› Verified 3 days ago
| Provider Name | Damarcus Rochoen Nelson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1194080499 PECOS PAC ID: 8123273877 Enrollment ID: I20130301000246 |
News Archive
University of Utah researchers have received $1.4 million to further develop an implantable neural interface that will allow an amputee to move an advanced prosthetic hand with just his or her thoughts. The neural interface will also convey feelings of touch and movement.
Findings published in the BMJ suggest that malaria is being significantly misdiagnosed in Afghanistan, with many patients with fever alone being given antimalarial drugs and antibiotics despite having negative laboratory results for the disease.
A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the drug hydroxychloroquine can benefit people infected with COVID-19, as well as whether taking the drug preventatively may help people avoid infection altogether.
Sheba Medical Center at Tel HaShomer and Immunicom, Inc. are initiating a ground-breaking clinical trial to evaluate the clinical effectiveness of the Immunicom LW-02 plasma filtration device as a monotherapy and in combination with an anti-PD-1 immune checkpoint inhibitor.
Prescription Solutions, a leading pharmacy benefits management (PBM) organization and a UnitedHealth Group (NYSE:UNH) company, today announced that it received the highest rankings for customer service and cost competitiveness factors among mail order pharmacies in the J.D. Power and Associates 2009 National Pharmacy StudySM.
› Verified 3 days ago
| Provider Name | Rachel Mack |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1558665067 PECOS PAC ID: 6406094408 Enrollment ID: I20130604000075 |
News Archive
University of Utah researchers have received $1.4 million to further develop an implantable neural interface that will allow an amputee to move an advanced prosthetic hand with just his or her thoughts. The neural interface will also convey feelings of touch and movement.
Findings published in the BMJ suggest that malaria is being significantly misdiagnosed in Afghanistan, with many patients with fever alone being given antimalarial drugs and antibiotics despite having negative laboratory results for the disease.
A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the drug hydroxychloroquine can benefit people infected with COVID-19, as well as whether taking the drug preventatively may help people avoid infection altogether.
Sheba Medical Center at Tel HaShomer and Immunicom, Inc. are initiating a ground-breaking clinical trial to evaluate the clinical effectiveness of the Immunicom LW-02 plasma filtration device as a monotherapy and in combination with an anti-PD-1 immune checkpoint inhibitor.
Prescription Solutions, a leading pharmacy benefits management (PBM) organization and a UnitedHealth Group (NYSE:UNH) company, today announced that it received the highest rankings for customer service and cost competitiveness factors among mail order pharmacies in the J.D. Power and Associates 2009 National Pharmacy StudySM.
› Verified 3 days ago
| Provider Name | Charles Pollard |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1497164396 PECOS PAC ID: 4183942683 Enrollment ID: I20150414000120 |
News Archive
University of Utah researchers have received $1.4 million to further develop an implantable neural interface that will allow an amputee to move an advanced prosthetic hand with just his or her thoughts. The neural interface will also convey feelings of touch and movement.
Findings published in the BMJ suggest that malaria is being significantly misdiagnosed in Afghanistan, with many patients with fever alone being given antimalarial drugs and antibiotics despite having negative laboratory results for the disease.
A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the drug hydroxychloroquine can benefit people infected with COVID-19, as well as whether taking the drug preventatively may help people avoid infection altogether.
Sheba Medical Center at Tel HaShomer and Immunicom, Inc. are initiating a ground-breaking clinical trial to evaluate the clinical effectiveness of the Immunicom LW-02 plasma filtration device as a monotherapy and in combination with an anti-PD-1 immune checkpoint inhibitor.
Prescription Solutions, a leading pharmacy benefits management (PBM) organization and a UnitedHealth Group (NYSE:UNH) company, today announced that it received the highest rankings for customer service and cost competitiveness factors among mail order pharmacies in the J.D. Power and Associates 2009 National Pharmacy StudySM.
› Verified 3 days ago
| Provider Name | Katherine M Cooper |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1578113833 PECOS PAC ID: 5294158853 Enrollment ID: I20200715000662 |
News Archive
University of Utah researchers have received $1.4 million to further develop an implantable neural interface that will allow an amputee to move an advanced prosthetic hand with just his or her thoughts. The neural interface will also convey feelings of touch and movement.
Findings published in the BMJ suggest that malaria is being significantly misdiagnosed in Afghanistan, with many patients with fever alone being given antimalarial drugs and antibiotics despite having negative laboratory results for the disease.
A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the drug hydroxychloroquine can benefit people infected with COVID-19, as well as whether taking the drug preventatively may help people avoid infection altogether.
Sheba Medical Center at Tel HaShomer and Immunicom, Inc. are initiating a ground-breaking clinical trial to evaluate the clinical effectiveness of the Immunicom LW-02 plasma filtration device as a monotherapy and in combination with an anti-PD-1 immune checkpoint inhibitor.
Prescription Solutions, a leading pharmacy benefits management (PBM) organization and a UnitedHealth Group (NYSE:UNH) company, today announced that it received the highest rankings for customer service and cost competitiveness factors among mail order pharmacies in the J.D. Power and Associates 2009 National Pharmacy StudySM.
› Verified 3 days ago
News Archive
University of Utah researchers have received $1.4 million to further develop an implantable neural interface that will allow an amputee to move an advanced prosthetic hand with just his or her thoughts. The neural interface will also convey feelings of touch and movement.
Findings published in the BMJ suggest that malaria is being significantly misdiagnosed in Afghanistan, with many patients with fever alone being given antimalarial drugs and antibiotics despite having negative laboratory results for the disease.
A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the drug hydroxychloroquine can benefit people infected with COVID-19, as well as whether taking the drug preventatively may help people avoid infection altogether.
Sheba Medical Center at Tel HaShomer and Immunicom, Inc. are initiating a ground-breaking clinical trial to evaluate the clinical effectiveness of the Immunicom LW-02 plasma filtration device as a monotherapy and in combination with an anti-PD-1 immune checkpoint inhibitor.
Prescription Solutions, a leading pharmacy benefits management (PBM) organization and a UnitedHealth Group (NYSE:UNH) company, today announced that it received the highest rankings for customer service and cost competitiveness factors among mail order pharmacies in the J.D. Power and Associates 2009 National Pharmacy StudySM.
› Verified 3 days ago
Aquilo Medical Home Team Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1491 Health Center Pkwy, Yukon, OK 73099 Phone: 405-990-6654 | |
Michael D. Furgeson, M. D.,inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 508 W Vandament Ave, Suite 100, Yukon, OK 73099 Phone: 405-350-8100 Fax: 405-350-6418 | |
Primary Health Partners Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1820 Commons Cir Ste B, Yukon, OK 73099 Phone: 405-265-2778 Fax: 405-494-7274 | |
Doyle Chiropractic And Family Wellness Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1050 W Vandament Ave, Yukon, OK 73099 Phone: 405-354-5753 Fax: 405-354-5828 | |
Catrina Bourne, Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1820 Commons Cir, Suite A, Yukon, OK 73099 Phone: 405-265-2778 Fax: 405-494-7274 | |
Serve Md Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 14540 W Wilshire Blvd, Yukon, OK 73099 Phone: 480-550-9096 | |
Family Urgent Care Yukon Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2525 Cornwell Drive, Yukon, OK 73099 Phone: 405-265-2300 |